Santini, Daniele
16 papers on CoChatORCID 0000-0002-9118-3337
Most cited papers
- Verified
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 2,144
- Verified
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., et al. (2022) · Annals of Oncology
Cancer survivorship and careHealth Systems, Economic Evaluations, Quality of Life
Cited by 509
- Verified
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
Cremolini, C., Rossini, D., Dell’Aquila, E., Lonardi, S., Conca, E., Del Re, M., Busico, A., Pietrantonio, F., Danesi, R., Aprile, G., et al. (2019) · JAMA Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 424
- Verified
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Cortellini, A., Bersanelli, M., Buti, S., Cannita, K., Santini, D., Perrone, F., Giusti, R., Tiseo, M., Michiara, M., Di Marino, P., et al. (2019) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersCancer Risks and Factors
Cited by 413
- Verified
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.
Loupakis, F., Pollina, L., Stasi, I., Ruzzo, A., Scartozzi, M., Santini, D., Masi, G., Graziano, F., Cremolini, C., Rulli, E., et al. (2009) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 403
- Verified
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Chi, K. N., Rathkopf, D., Smith, M. R., Efstathiou, E., Attard, G., Olmos, D., Lee, J. Y., Small, E. J., Pereira de Santana Gomes, A. J., Roubaud, G., et al. (2023) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy
Cited by 355
- Verified
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open
Cancer survivorship and careMental Health Treatment and Access
Cited by 316
- Verified
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Cortellini, A., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Bisonni, R., Santini, D., et al. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Cited by 275
- Verified
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
Santini, D., Loupakis, F., Vincenzi, B., Floriani, I., Stasi, I., Canestrari, E., Rulli, E., Maltese, P. E., Andreoni, F., Masi, G., et al. (2008) · The Oncologist
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 234
- Verified
Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline
Grassi, L., Zachariae, R., Caruso, R., Palagini, L., Campos-Ródenas, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., et al. (2023) · ESMO Open
Sleep and related disordersCancer survivorship and care
Cited by 96
- Verified
Circulating VEGF Reduction, Response and Outcome in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan
Vincenzi, B., Santini, D., Russo, A., Gavasci, M., Battistoni, F., Dicuonzo, G., Rocci, L., Rosaria, V. M., Gebbia, N., & Tonini, G. (2007) · Pharmacogenomics
Colorectal Cancer Treatments and StudiesAngiogenesis and VEGF in Cancer
Cited by 38
- Verified
Network approach in liquidomics landscape
Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research
Cancer Genomics and DiagnosticsExtracellular vesicles in disease
Cited by 37
- Verified
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
Bronte, G., Rolfo, C., Passiglia, F., Rizzo, S., Gil-Bazo, I., Fiorentino, E., Cajozzo, M., Van Meerbeeck, J. P., Lequaglie, C., Santini, D., et al. (2015) · Critical Reviews in Oncology/Hematology
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 32
- Verified
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
Mallio, C. A., Napolitano, A., Castiello, G., Giordano, F. M., D'Alessio, P., Iozzino, M., Sun, Y., Angeletti, S., Russano, M., Santini, D., et al. (2021) · Cancers
COVID-19 diagnosis using AIRadiomics and Machine Learning in Medical Imaging
Cited by 30
- Verified
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
Cursano, M. C., Kopf, B., Scarpi, E., Menna, C., Casadei, C., Schepisi, G., Lolli, C., Altavilla, A., Gallà, V., Santini, D., et al. (2020) · Frontiers in Oncology
Inflammatory Biomarkers in Disease PrognosisTesticular diseases and treatments
Cited by 19
- Verified
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
Rossini, D., Boccaccino, A., Sbrana, A., Daniel, F., Borelli, B., Raimondi, A., Santini, D., Conca, V., Tomasello, G., Caponnetto, S., et al. (2021) · ESMO Open
Neutropenia and Cancer InfectionsColorectal Cancer Treatments and Studies
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free